<div id="readability-page-1"><div><p>Health care stocks followed the main indexes in a post-holiday decline, before bouncing back to close slightly higher, among a lack of market-moving news and data points.</p><p>    Arcadia Biosciences declined after the termination of a merger agreement with Roosevelt Resources that was announced just over a year ago. The company will resume its evaluation of strategic alternatives. </p><p>    Moderna, a major stock in the sector, was a top loser in the S&amp;P 500, although no particular piece of news seemed to be the culprit. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-26-25 1751ET</p></div></div>

MRNA

<p>医疗保健股票在假期后最初下跌，但随后恢复并小幅收高。Arcadia Biosciences 在与 Roosevelt Resources 结束合并后股价下跌，而 Moderna 在没有具体消息导致下跌的情况下成为标准普尔 500 指数中的最大输家</p>

医疗保健股票在尾盘交易中反弹——医疗保健综述